Johnson & Johnson’s (J&J; New Brunswick, New Jersey) Cordis(Miami Lakes, Florida) subsidiary, maker of the recently FDA-approved Cypher drug-eluting stent, and to a lesser extent Wyeth (Madison, New Jersey), maker of the sirolimus compound used on the device, have received the lion’s share of the attention when talking about the first U.S. player in this hot sector.